Omega Therapeutics

Omega Therapeutics company information, Employees & Contact Information

Omega Therapeutics is a clinical-stage biotechnology company pioneering the first systematic approach of using mRNA as programmable epigenomic medicines. Our OMEGA platform harnesses the power of epigenetics, the mechanism that controls gene expression and every aspect of an organism's life from cell genesis, growth and differentiation to cell death. The OMEGA platform enables control of fundamental epigenetic processes to correct the root cause of disease by returning aberrant gene expression to a normal range without altering native nucleic acid sequences. Omega’s engineered, modular, and programmable mRNA medicines, Omega Epigenomic Controllers™, target specific intervention points amongst the thousands of mapped and validated novel DNA-sequence-based epigenomic loci to durably tune single or multiple genes to treat and cure disease through unprecedented precision epigenomic control. Omega has a broad pipeline of development candidates spanning a range of disease areas, including oncology, regenerative medicine, multigenic diseases including immunology, and select monogenic diseases.

Company Details

Employees
30
Founded
-
Address
20 Acorn Park Dr,
Phone
212-600-1902
Email
Ar****@****ers.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Keywords
jobs.
HQ
Cambridge, Massachusetts
Looking for a particular Omega Therapeutics employee's phone or email?

Omega Therapeutics Questions

News

Flagship's Omega sinks toward bankruptcy, lays off staff 13 months after inking Novo obesity pact - Fierce Biotech

Flagship's Omega sinks toward bankruptcy, lays off staff 13 months after inking Novo obesity pact Fierce Biotech

Biotech Firm Omega Therapeutics Gets OK For Ch. 11 Plan - Law360

Biotech Firm Omega Therapeutics Gets OK For Ch. 11 Plan Law360

Omega Therapeutics to sell assets amid Nasdaq delisting - Investing.com

Omega Therapeutics to sell assets amid Nasdaq delisting Investing.com

Omega Therapeutics Announces Successful Completion of Phase - GlobeNewswire

Omega Therapeutics Announces Successful Completion of Phase GlobeNewswire

Novo Partner Omega Waves Bankruptcy Flag from Sinking Ship - BioSpace

Novo Partner Omega Waves Bankruptcy Flag from Sinking Ship BioSpace

Omega Therapeutics Faces Leadership Change and Takeover Proposal - Yahoo Finance

Omega Therapeutics Faces Leadership Change and Takeover Proposal Yahoo Finance

Omega Therapeutics Hits Chapter 11 - USA Herald

Omega Therapeutics Hits Chapter 11 USA Herald

Omega Therapeutics Appoints Jennifer Nelson, Ph.D., as Senior Vice President of Research - citybiz

Omega Therapeutics Appoints Jennifer Nelson, Ph.D., as Senior Vice President of Research citybiz

Biotech Firm Omega Therapeutics OK'd For $14M Ch. 11 Sale - Law360

Biotech Firm Omega Therapeutics OK'd For $14M Ch. 11 Sale Law360

Flagship-backed Omega signals it’s headed toward bankruptcy - BioPharma Dive

Flagship-backed Omega signals it’s headed toward bankruptcy BioPharma Dive

Omega Therapeutics enters restructuring agreement - Investing.com

Omega Therapeutics enters restructuring agreement Investing.com

Omega Therapeutics to Advance Pipeline and Platform Development with $126 Million in Additional Financing - PR Newswire

Omega Therapeutics to Advance Pipeline and Platform Development with $126 Million in Additional Financing PR Newswire

Omega Therapeutics to Present New Preclinical Data on Epigenomic Upregulation at the American Society of Gene and Cell Therapy 27th Annual Meeting - Yahoo Finance

Omega Therapeutics to Present New Preclinical Data on Epigenomic Upregulation at the American Society of Gene and Cell Therapy 27th Annual Meeting Yahoo Finance

Omega Therapeutics Appoints Chris Schade to its Board of Directors - citybiz

Omega Therapeutics Appoints Chris Schade to its Board of Directors citybiz

Biotech Firm Omega Therapeutics Hits Ch. 11 To Restructure - Law360

Biotech Firm Omega Therapeutics Hits Ch. 11 To Restructure Law360

Omega Therapeutics Announces Pricing of Initial Public Offering - PR Newswire

Omega Therapeutics Announces Pricing of Initial Public Offering PR Newswire

Novo Nordisk enters into research collaborations with Omega - GlobeNewswire

Novo Nordisk enters into research collaborations with Omega GlobeNewswire

Omega Therapeutics Announces Updates to its Board of Directors - Yahoo Finance

Omega Therapeutics Announces Updates to its Board of Directors Yahoo Finance

Omega Therapeutics Appoints Rainer Boehm to its Board of Directors - citybiz

Omega Therapeutics Appoints Rainer Boehm to its Board of Directors citybiz

Omega Therapeutics Announces FDA Clearance of IND Application for OTX-2002, First Omega Epigenomic Controller, for MYC Driven Hepatocellular Carcinoma - PR Newswire

Omega Therapeutics Announces FDA Clearance of IND Application for OTX-2002, First Omega Epigenomic Controller, for MYC Driven Hepatocellular Carcinoma PR Newswire

Omega Therapeutics Announces First Patient Dosed in Landmark MYCHELANGELO™ I Trial of OTX-2002 in Hepatocellular Carcinoma and Other Solid Tumor Types Associated with the MYC Oncogene - PR Newswire

Omega Therapeutics Announces First Patient Dosed in Landmark MYCHELANGELO™ I Trial of OTX-2002 in Hepatocellular Carcinoma and Other Solid Tumor Types Associated with the MYC Oncogene PR Newswire

Case Summary: Omega Therapeutics Chapter 11 - Bondoro

Case Summary: Omega Therapeutics Chapter 11 Bondoro

Omega Therapeutics secures $9.8M in DIP financing - Investing.com

Omega Therapeutics secures $9.8M in DIP financing Investing.com

Omega Therapeutics Advances Controllable Epigenomic Programming Platform to Deliver a Pipeline of Novel Therapeutics with $85M in Financing - Business Wire

Omega Therapeutics Advances Controllable Epigenomic Programming Platform to Deliver a Pipeline of Novel Therapeutics with $85M in Financing Business Wire

Omega Therapeutics And Novo Nordisk Collaboration: A Cautious 'Buy' (NASDAQ:OMGA) - Seeking Alpha

Omega Therapeutics And Novo Nordisk Collaboration: A Cautious 'Buy' (NASDAQ:OMGA) Seeking Alpha

Novo Nordisk offers 2 Flagship biotechs up to $1B total for obesity, MASH deals - Fierce Biotech

Novo Nordisk offers 2 Flagship biotechs up to $1B total for obesity, MASH deals Fierce Biotech

Omega Therapeutics Initiates Restructuring Amid Financial Challenges - TipRanks

Omega Therapeutics Initiates Restructuring Amid Financial Challenges TipRanks

Barbara Chan Succeeds Current CFO of Omega Therapeutics Joshua Reed - CEOWORLD magazine

Barbara Chan Succeeds Current CFO of Omega Therapeutics Joshua Reed CEOWORLD magazine

Omega Therapeutics (OMGA) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now - Nasdaq

Omega Therapeutics (OMGA) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now Nasdaq

Top Omega Therapeutics Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant